Figure 2From: The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence Immunohistochemical staining of HER2 + breast cancer with monoclonal anti-TRMT2A (S0722). Back to article page